Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Real-world Practice Patterns and Safety of Concurrent Radiotherapy and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumEur Urol Focus 2022 Oct 31;[EPub Ahead of Print], C Loo Gan, J Huang, E Pan, W Xie, AL Schmidt, C Labaki, L Meza, G Bouchard, H Li, F Jackson-Spence, C Sánchez-Ruiz, T Powles, SA Kumar, N Weise, WA Hall, BS Rose, B Beuselinck, C Suarez, SK Pal, TK Choueiri, DYC Heng, RR McKay
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.